Tibet Weixinkang Medicine Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 40.81%

Tibet Weixinkang Medicine Co Ltd (603676) has an Asset Resilience Ratio of 40.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tibet Weixinkang Medicine Co Ltd (603676) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥796.00 Million

≈ $116.48 Million USD Cash + Short-term Investments

Total Assets

CN¥1.95 Billion

≈ $285.44 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Tibet Weixinkang Medicine Co Ltd's Asset Resilience Ratio has changed over time. See 603676 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Tibet Weixinkang Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tibet Weixinkang Medicine Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥796.00 Million	40.81%
Total Liquid Assets	CN¥796.00 Million	40.81%

Asset Resilience Insights

Very High Liquidity: Tibet Weixinkang Medicine Co Ltd maintains exceptional liquid asset reserves at 40.81% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Tibet Weixinkang Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tibet Weixinkang Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Tibet Weixinkang Medicine Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Tibet Weixinkang Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	41.25%	CN¥770.00 Million ≈ $112.68 Million	CN¥1.87 Billion ≈ $273.18 Million	-2.07pp
2024-12-31	43.32%	CN¥803.00 Million ≈ $117.50 Million	CN¥1.85 Billion ≈ $271.25 Million	+8.13pp
2023-12-31	35.19%	CN¥625.32 Million ≈ $91.50 Million	CN¥1.78 Billion ≈ $260.02 Million	+17.95pp
2022-12-31	17.24%	CN¥287.00 Million ≈ $42.00 Million	CN¥1.66 Billion ≈ $243.60 Million	-14.04pp
2021-12-31	31.28%	CN¥467.77 Million ≈ $68.45 Million	CN¥1.50 Billion ≈ $218.85 Million	+5.10pp
2020-12-31	26.18%	CN¥356.00 Million ≈ $52.09 Million	CN¥1.36 Billion ≈ $199.02 Million	-2.18pp
2019-12-31	28.35%	CN¥369.90 Million ≈ $54.13 Million	CN¥1.30 Billion ≈ $190.91 Million	-9.68pp
2017-12-31	38.04%	CN¥386.71 Million ≈ $56.59 Million	CN¥1.02 Billion ≈ $148.76 Million	+23.83pp
2016-12-31	14.21%	CN¥78.50 Million ≈ $11.49 Million	CN¥552.36 Million ≈ $80.83 Million	--

pp = percentage points

About Tibet Weixinkang Medicine Co Ltd

SHG:603676 China Drug Manufacturers - Specialty & Generic

Market Cap

$550.18 Million

CN¥3.76 Billion CNY

Market Cap Rank

#11878 Global

#3439 in China

Share Price

CN¥8.64

Change (1 day)

+0.47%

52-Week Range

CN¥8.60 - CN¥14.17

All Time High

CN¥24.05